Article
Cytokine profiles, genetic polymorphisms, and systemic inflammatory markers in type 1 diabetes patients with COVID-19: IL-18 a predictor of disease severity.
Frontiers in immunology - 1 Jan 2026
Abdullah Mohammed Yousif, Laaribi Ahmed Baligh, Babay Wafa, Alhaddad Farah Abdulkhaleq Khattab, Mehri Asma, Ouzari Hadda-Imene, Marghali Sonia
Abstract excerpt
Background: Patients with Type 1 Diabetes Mellitus (T1DM) are at increased risk for severe COVID-19 due to chronic inflammation, immune dysregulation, and impaired antiviral responses. However, the combined contribution of cytokine imbalance, host genetic variation, and systemic inflammation on COVID-19 severity in this population remains incompletely understood. This study aimed to investigate inflammatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
